πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 109 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10821092

Viscous topical ocular formulations

Encompass Development, Inc. Β· Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10806697

Vaginal inserted estradiol pharmaceutical compositions and methods

Compass Therapeutics LLC Β· Granted Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10806740

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC Β· Granted Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10716851

Agonist antibodies that bind human CD137 and uses thereof

Compass Therapeutics LLC Β· Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10675288

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10668082

Vaginal inserted estradiol pharmaceutical compositions and methods

Compass Therapeutics LLC Β· Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10639375

Progesterone formulations

Compass Therapeutics LLC Β· Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10568891

Vaginal inserted estradiol pharmaceutical compositions and methods

Compass Therapeutics LLC Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10537581

Vaginal inserted estradiol pharmaceutical compositions and methods

Compass Therapeutics LLC Β· Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10532059

Steroid hormone pharmaceutical composition

Compass Therapeutics LLC Β· Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10519175

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and th

COMPASS Pathways Limited Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10471072

Vaginal inserted estradiol pharmaceutical compositions and methods

Compass Therapeutics LLC Β· Granted Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10471148

Progesterone formulations having a desirable PK profile

Compass Therapeutics LLC Β· Granted Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10441546

Bacterially derived intact minicells that encompass plasmid free DNA and methods of using

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10434175

Agonist antibodies that bind human CD137 and uses thereof

Compass Therapeutics LLC Β· Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10398708

Vaginal inserted estradiol pharmaceutical compositions and methods

Compass Therapeutics LLC Β· Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10383827

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10369098

Methods for localized drug delivery

Compass Therapeutics LLC Β· Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10350292

Agonist antibodies that bind human CD137 and uses thereof

Compass Therapeutics LLC Β· Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10328087

Formulations for solubilizing hormones

Compass Therapeutics LLC Β· Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10308698

Therapeutic targeting of SET1B/compass pathway for treating cancers

Northwestern University Β· Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10286077

Steroid hormone compositions in medium chain oils

Compass Therapeutics LLC Β· Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10279038

Agonist antibodies that bind human CD137 and uses thereof

Compass Therapeutics LLC Β· Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10279040

Agonist antibodies that bind human CD137 and uses thereof

Compass Therapeutics LLC Β· Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted